Literature DB >> 1686109

Cholinoceptor blockers protect against ethanol-induced gastric mucosal damage in rats.

C H Cho1, C W Ogle.   

Abstract

The role of the cholinergic nervous system in ethanol-induced gastric mucosal damage has been examined in rats. Oral administration of 50 or 80% ethanol produced haemorrhagic lesions which were reduced by atropine pretreatment (0.65, 2.5, 5 or 10 mg/kg injected i.p.); there was lesser protection against the higher dose of ethanol. Pirenzepine (a specific M1 receptor antagonist) pretreatment (0.1, 0.2, 1 or 2 mg/kg, injected s.c.) also protected against ethanol-induced gastric injury to a similar extent; it also increased the amount of adherent mucus on the glandular mucosa. This action may, therefore, account for the protective action of the ganglion blocker. It is concluded that ethanol may stimulate the stomach wall ganglionic nicotinic receptors to activate the postganglionic fibres and subsequently the muscarinic receptors which would then trigger off some of the ulcerogenic mechanisms in the stomach. However, ethanol could also produce gastric damage via the non-cholinergic mechanisms; this action becomes more prominent in gastric injury produced by high doses of ethanol.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686109     DOI: 10.1159/000138860

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  3 in total

1.  Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs.

Authors:  J K Ko; C H Cho
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

2.  Intragastric nicotine protection against 40% ethanol injury in rat stomach. Role of ganglionic stimulation or blockade.

Authors:  K Endoh; J Kao; M Baker; F W Leung
Journal:  Dig Dis Sci       Date:  1992-12       Impact factor: 3.199

3.  Validation of octanoate breath test for measuring gastric emptying in rats.

Authors:  Ingrid Demedts; Christophe Vanormelingen; Hubert Van Billoen; Tim Vanuytsel; Ricard Farré; Tatsuhiro Masaoka; Alfons Verbruggen; Kristien Verbeke; Pieter Vanden Berghe; Jan Tack
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.